RONALD LITMAN: Open Payments
NPI 1578059630 · MARION, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,993 in 45 payments from 13 companies in 2025. Trend: 2023 $807 · 2024 $3,315 · 2025 $1,993
Consulting: $1,290Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| Ascensia Diabetes Care Us Inc. | 4 | $1,298 |
| ABBVIE INC. | 13 | $215 |
| Novo Nordisk Inc | 6 | $92 |
| GlaxoSmithKline, LLC. | 4 | $59 |
| Corcept Therapeutics | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Amgen Inc. | 3 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| PFIZER INC. | 2 | $31 |
Products named: UBRELVY, VRAYLAR, Rybelsus, TRELEGY ELLIPTA, Korlym, LINZESS, XIFAXAN, FANAPT.
Industry payments across OH — which companies pay providers there.
